Key Insights Repligen will host its Annual General Meeting on 16th of May CEO Tony Hunt's total compensation includes...
WALTHAM, Mass., May 07, 2024 (GLOBE NEWSWIRE) -- Repligen Corporation (NASDAQ:RGEN), a life sciences company focused on bioprocessing technology leadership, today announced that it will be participating at the following May investor conferences. RBC Capital Markets’ 2024 Global Healthcare Conference, being held in New York on May 14-15. Jason K. Garland, Chief Financial Officer, is scheduled to participate in an analyst-led discussion on May 14, 2024 at 10:30 a.m. ET, in addition to a series of
Repligen ( NASDAQ:RGEN ) First Quarter 2024 Results Key Financial Results Revenue: US$151.3m (down 17% from 1Q 2023...